Westmead Hospital
Wentworthville, New South Wales NSW2145
0 studies enrolling now · 13 studies all time
What they study most
Cancer of the Uterine Cervix, Chronic Lymphocytic Leukemia, Chronic Shift Work Sleep Disorder, Endometrial Cancer, Excessive Daytime Sleepiness, HIV Infection, HIV Infections, Huntington Disease, Huntington's Disease, Influenza, Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome), Narcolepsy
Studies at this site
- Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
- Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
- A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
- A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer — Completed
- Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP) — Completed
- Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed
- Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer — Completed
- Expanded Access Program for Maraviroc At Multiple Centers — Completed
- Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir — Completed
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) — Stopped early
- Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza — Completed
- Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness — Completed
- Cooperative Huntington's Observational Research Trial — Status unconfirmed